NUTRIBAND INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.72 USD | -6.53% |
|
+40.48% | +103.45% |
| 01/05 | Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021. | CI |
| 01/05 | Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021. | CI |
Valuation
| Fiscal Period: January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 157.6 | 74.58 | 112.6 | 33.97 | 28.59 | 22.08 |
| Enterprise Value (EV) 1 | 157.2 | 74.89 | 114.3 | 29.21 | 26.79 | 21.83 |
| P/E ratio | -46.3 x | -27.4 x | -35.4 x | -4.66 x | -6.89 x | -3.78 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 643 x | 201 x | 119 x | 23.9 x | 13.7 x | 10.6 x |
| EV / Revenue | 641 x | 202 x | 121 x | 20.5 x | 12.9 x | 10.5 x |
| EV / EBITDA | -47.7 x | -39.5 x | -46.9 x | -8.07 x | -7.02 x | -4.76 x |
| EV / FCF | 1,373 x | 135 x | -744 x | -19.2 x | -16.3 x | -12.2 x |
| FCF Yield | 0.07% | 0.74% | -0.13% | -5.22% | -6.14% | -8.22% |
| Price to Book | 65 x | 426 x | 15.8 x | 2.89 x | 3.34 x | 3.59 x |
| Nbr of stocks (in thousands) | 6,386 | 6,328 | 7,300 | 9,070 | 7,833 | 8,460 |
| Reference price 2 | 24.69 | 11.79 | 15.43 | 3.746 | 3.650 | 2.610 |
| Announcement Date | 19/04/19 | 14/04/20 | 02/04/21 | 29/04/22 | 26/04/23 | 01/05/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.2453 | 0.3706 | 0.9437 | 1.422 | 2.08 | 2.085 |
| EBITDA 1 | -3.294 | -1.897 | -2.436 | -3.621 | -3.818 | -4.584 |
| EBIT 1 | -3.331 | -1.969 | -2.596 | -3.93 | -4.148 | -4.872 |
| Operating Margin | -1,358.11% | -531.35% | -275.08% | -276.33% | -199.45% | -233.63% |
| Earnings before Tax (EBT) 1 | -3.331 | -2.722 | -2.933 | -6.176 | -4.483 | -5.485 |
| Net income 1 | -3.331 | -2.722 | -2.933 | -6.176 | -4.483 | -5.485 |
| Net margin | -1,358.11% | -734.29% | -310.78% | -434.28% | -215.59% | -263.04% |
| EPS 2 | -0.5335 | -0.4301 | -0.4356 | -0.8033 | -0.5300 | -0.6900 |
| Free Cash Flow 1 | 0.1145 | 0.5553 | -0.1536 | -1.524 | -1.646 | -1.794 |
| FCF margin | 46.69% | 149.83% | -16.28% | -107.18% | -79.13% | -86.04% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19/04/19 | 14/04/20 | 02/04/21 | 29/04/22 | 26/04/23 | 01/05/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: January | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.283 | 0.4919 | 0.4779 | 0.4562 | 0.618 | 0.5275 |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | -1.538 | -1.594 | -0.6859 | -1.034 | -1.072 | -2.011 |
| Operating Margin | -543.54% | -324.11% | -143.51% | -226.73% | -173.39% | -381.18% |
| Earnings before Tax (EBT) | -1.572 | -3.768 | - | -1.039 | - | - |
| Net income 1 | -1.768 | -3.768 | -0.69 | -1.039 | -1.075 | -1.679 |
| Net margin | -624.79% | -766.11% | -144.37% | -227.71% | -174.03% | -318.33% |
| EPS 2 | -0.2314 | -0.4629 | -0.0771 | -0.1200 | -0.1400 | -0.2100 |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 14/12/21 | 29/04/22 | 31/05/22 | 08/09/22 | 02/12/22 | 26/04/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 0.31 | 1.64 | - | - | - |
| Net Cash position 1 | 0.43 | - | - | 4.76 | 1.8 | 0.25 |
| Leverage (Debt/EBITDA) | - | -0.1642 x | -0.6716 x | - | - | - |
| Free Cash Flow 1 | 0.11 | 0.56 | -0.15 | -1.52 | -1.65 | -1.79 |
| ROE (net income / shareholders' equity) | -264% | -211% | -80.5% | -65.1% | -43.9% | -73.1% |
| ROA (Net income/ Total Assets) | -140% | -49.2% | -26.8% | -21.7% | -23.4% | -35.9% |
| Assets 1 | 2.378 | 5.534 | 10.96 | 28.5 | 19.19 | 15.29 |
| Book Value Per Share 2 | 0.3800 | 0.0300 | 0.9700 | 1.300 | 1.090 | 0.7300 |
| Cash Flow per Share 2 | 0.0800 | 0 | 0.0200 | 0.5300 | 0.2500 | 0.0600 |
| Capex 1 | 0 | - | - | 0.08 | 0.08 | 0.05 |
| Capex / Sales | 1.7% | - | - | 5.74% | 3.81% | 2.48% |
| Announcement Date | 19/04/19 | 14/04/20 | 02/04/21 | 29/04/22 | 26/04/23 | 01/05/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +103.45% | 51.73M | |
| -4.72% | 182B | |
| +3.96% | 114B | |
| -2.93% | 68.38B | |
| +6.30% | 52.46B | |
| +8.02% | 44.25B | |
| +7.52% | 43.55B | |
| +26.18% | 32.69B | |
| +17.85% | 26.73B | |
| +0.57% | 25.79B |
- Stock Market
- Equities
- NTRB Stock
- Financials Nutriband Inc.
